New Data On Part D Prescription Drugs Available

B
BakerHostetler

Contributor

BakerHostetler logo
Recognized as one of the top firms for client service, BakerHostetler is a leading national law firm that helps clients around the world address their most complex and critical business and regulatory issues. With five core national practice groups — Business, Labor and Employment, Intellectual Property, Litigation, and Tax — the firm has more than 970 lawyers located in 14 offices coast to coast. BakerHostetler is widely regarded as having one of the country’s top 10 tax practices, a nationally recognized litigation practice, an award-winning data privacy practice and an industry-leading business practice. The firm is also recognized internationally for its groundbreaking work recovering more than $13 billion in the Madoff Recovery Initiative, representing the SIPA Trustee for the liquidation of Bernard L. Madoff Investment Securities LLC. Visit bakerlaw.com
CMS created the dataset using drug claim information submitted by Medicare Advantage Prescription Drug plans and stand-alone Prescription Drug Plans.
United States Food, Drugs, Healthcare, Life Sciences

On April 30, 2015, the Centers for Medicare & Medicaid Services (CMS) made available a dataset that provides detailed information on medications that physicians and other healthcare providers prescribed under the Medicare Part D Prescription Drug Program in 2013. CMS intends for this dataset to provide "key information to consumers, providers, researchers, and other stakeholders to help drive transformation of the health care delivery system."

The prescribing providers included in the dataset represent more than one million distinct healthcare providers who collectively prescribed over $100 billion in prescription drugs under the Medicare Part D program. This dataset describes the specific drugs prescribed and statistics on their utilization and costs. For each prescribing provider and medication, the dataset includes the total number of prescriptions that were dispensed, which include original prescriptions and any refills, and the total drug cost paid by beneficiaries, Part D plans, and other sources.

CMS created the dataset using drug claim information submitted by Medicare Advantage Prescription Drug plans and stand-alone Prescription Drug Plans. With the information included in the dataset, it will be possible to conduct a wide range of analyses that compare drug use and costs for specific providers and brand versus generic drug prescribing rates, and to make geographic comparisons at the state level.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More